Balbin, Edzel Dave .
HRN: 28-70-25 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/24/2026
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
03/25/2026
03/25/2026
IV
500 Mg
PTOR
For Elective Open Reduction
Pending Pharmacy Acceptance
Indication: Prophylaxis Type of Infection: Prophylaxis Compliance to guidelines: